1. Market Research
  2. > Pathology
63 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Vaginal Cancer - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 381 pages

It is in Phase I stage of development for diffuse large B cell lymphoma and high-grade B cell lymphoma.

  • Lung Cancer
  • Lymphoma
  • Sexually Transmitted Disease
  • United States
  • F. Hoffmann-La Roche Ltd.

Transplant Diagnostics Market - Global Outlook and Forecast 2020-2025

  • $ 3500
  • February 2020
  • 284 pages

EXHIBIT ## GLOBAL LEUKEMIA INCIDENCE IN 2018 Stem cell transplantation is used for the treatment of a wide variety of diseases, including leukemia and lymphoma.

  • Diagnostics
  • Lymphoma
  • Transplantation
  • World
  • F. Hoffmann-La Roche Ltd.

Global Biologics Market: Size, Trends & Forecast (2019-2023 Edition)

  • $ 1200
  • December 2019
  • 97 pages

Enbrel ##. ## Rheumatoid arthritis Amgen, Pfizer Herceptin ##. ## Breast and gastric cancer Roche (Genentech) Avastin ##. ## Various cancers Roche (Genentech) Rituxin ##. ## Lymphoma, Rheumatoid arthritis Roche (Genentech), Biogen Eylea ##. ## Macular degeneration/ edema, retinopathy Bayer, Regeneron

  • Lymphoma
  • Medical Biotechnology
  • Pharmaceutical
  • World
  • F. Hoffmann-La Roche Ltd.

Vaginal Cancer - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 351 pages

It is in Phase I stage of development for diffuse large B cell lymphoma and high-grade B cell lymphoma.

  • Cancer
  • Lung Cancer
  • Lymphoma
  • United States
  • F. Hoffmann-La Roche Ltd.

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2020

  • $ 2000
  • April 2020
  • 403 pages

It is in Phase I stage of development for diffuse large B cell lymphoma and high-grade B cell lymphoma.

  • Lung Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • F. Hoffmann-La Roche Ltd.

Cancer Biomarkers Market to 2027 - Global Analysis and Forecasts By Biomarker Type; Profiling Technology; Cancer Type; Application and Geography

  • $ 4550
  • October 2019
  • 241 pages

According to the Leukemia and Lymphoma Society, in the United stated it is estimated that ##, ## people living with or in remission from leukemia and ##, ## people are expected to be diagnosed with leukemia and also ##, ## people are expected to die from leukemia in 2019.

  • Biomarker
  • Cancer
  • Lymphoma
  • Market Size
  • F. Hoffmann-La Roche Ltd.

AIDS - Related Lymphoma Global Clinical Trials Review, H2, 2018

  • $ 2500
  • October 2018
  • 74 pages

AIDS - Related Lymphoma Global Clinical Trials Review, H##, 2018 H e a l t h c a r e H e a l t h c a r e REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: OCT 2018 LIST OF TABLES LIST OF FIGURES AIDS - Related Lymphoma Global Clinical Trials Review, H##, 2018 outlines clinical trials i

  • HIV AIDS
  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • F. Hoffmann-La Roche Ltd.

Global Immuno-Oncology Market with Focus on Assays: Size, Trends and Forecasts (2019-2023)

  • $ 900
  • September 2019
  • 77 pages

On July ##, 2019, the US Food and Drug Administration (FDA) approved RUXIENCE, a biosimilar to Rituxan to treat the adult patients with lymphoma, leukemia and polyangiitis.

  • Lymphoma
  • Oncology
  • Therapy
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.

Global Tissue Diagnostics Market 2018-2022

  • $ 2500
  • June 2018
  • 134 pages

Based on the cell type, there are five main cancer groups, namely carcinomas, lymphomas, leukemias, brain tumors, and sarcomas.

  • Healthcare
  • Lymphoma
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.

Italy In Vitro Diagnostics Market Outlook to 2025 - Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.

  • $ 5995
  • April 2020
  • 360 pages

AN INITIAL PHASE ## CLINICAL TRIAL WILL EVALUATE THE ABILITY OF BP## TO TREAT REFRACTORY/ RELAPSED LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS.

  • In Vitro Diagnostics
  • Lymphoma
  • Italy
  • Southern Europe
  • F. Hoffmann-La Roche Ltd.

Global Biotechnology, MarketLine

  • $ 350
  • June 2018
  • 34 pages

lymphoma (FL), RA and certain types of ANCA-associated vasculitis, Actemra/ RoActemra, for rheumatoid arthritis, systemic juvenile idiopathic arthritis and polyarticular juvenile idiopathic arthritis, Xolair, for moderate to severe persistent allergic asthma and chronic idiopathic urtic

  • Biotechnology
  • Lymphoma
  • Amgen Inc.
  • Covance Inc.
  • F. Hoffmann-La Roche Ltd.

Kidney Cancer Therapeutics & Diagnostics Market- Growth, Trends, and Forecasts (2020 – 2025)

  • $ 4250
  • July 2020
  • 135 pages

ADCETRIS is approved for some CD##-expressing lymphomas, while PADCEV is approved for certain metastatic urothelial cancers.

  • Diagnostics
  • Lymphoma
  • Renal Cancer
  • Therapy
  • F. Hoffmann-La Roche Ltd.

Precision Medicine Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 4250
  • December 2019
  • 112 pages

PREDICTIVE BIOMARKERS FOR PRECISION MEDICINE IN LUNG CANCER THERAPY ARE DONE WITH DRUGS TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), ANAPLASTIC LYMPHOMA KINASE (ALK), C-ROS ONCOGENE-## RECEPTOR TYROSINE KINASE (ROS##), AND IMMUNE CHECKPOINTS.

  • Healthcare
  • Lymphoma
  • Biocrates Life Sciences AG
  • F. Hoffmann-La Roche Ltd.
  • NanoString Technologies, Inc.

The State of Personalized/ Precision Medicine

  • $ 7995
  • October 2019
  • 119 pages

BeiGene Ovarian cancer Rhythm Pharmaceuticals Pro-opiomelanocortin (POMC) deficiency obesity, leptin receptor (LEPR) deficiency obesity Denovo Biopharma Diffuse large B-cell lymphoma (DLBCL) Genentech/ Roche Solid tumors GenSight Biologics Leber' s hereditary optic neuropathy (LHON)

  • Lymphoma
  • Therapy
  • United States
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.

Asia-Pacific Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality ; End User, and Country

  • $ 3000
  • March 2020
  • 166 pages

The largest impact is that it grows slowly, like solid tumors and leukemia, also used to treat lung, ovarian cancer, and breast cancer, as well as for lymphomas, sarcomas, myelomas.

  • Colorectal Cancer
  • Lymphoma
  • APAC
  • Market Size
  • F. Hoffmann-La Roche Ltd.

Biopharmaceuticals Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 5000
  • August 2019
  • 178 pages

According to the Leukemia and Lymphoma Society (LLS), United States, an estimated combined total of ##, ## people in the United States are expected to be diagnosed with leukemia, lymphoma, or myeloma in 2019.

  • Biopharmaceutical
  • Lymphoma
  • Medical Biotechnology
  • United States
  • F. Hoffmann-La Roche Ltd.

Global Biologics Market: Size, Trends & Forecast (2018-2022)

  • $ 900
  • February 2018
  • 91 pages

Global Biologics Market: Size, Trends & Forecasts (2018-2022) February 2018 ##.

  • Biotech Services
  • Lymphoma
  • Medical Biotechnology
  • World
  • F. Hoffmann-La Roche Ltd.

Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality ; End User , and Country

  • $ 3000
  • February 2020
  • 229 pages

The largest impact is that it grows slowly, like solid tumors and leukemia, also used to treat lung, ovarian cancer, and breast cancer, as well as for lymphomas, sarcomas, myelomas.

  • Colorectal Cancer
  • Immunotherapy
  • Lymphoma
  • Market Size
  • F. Hoffmann-La Roche Ltd.

South Africa In-Vitro Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)

  • $ 3250
  • November 2019
  • 69 pages

Some of the most common blood disorders in the country include anaemia, sickle cell anaemia, lymphoma, leukaemia, idiopathic thrombocytopenic purpura, primary thrombocythemia, sepsis, and hemophilia, among others.

  • In Vitro Diagnostics
  • Lymphoma
  • South Africa
  • Abbott Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.

Companion Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

  • $ 4250
  • April 2020
  • 113 pages

In January 2018, NanoString Technologies and Riken Genesis of Kawasaki entered a collaboration to register, obtain reimbursement, and commercialize companion diagnostic assays in Japan, including NanoString' s Lymphoma Subtyping Test, which will be marketed as the nCounter Dx LymphMarkT

  • Diagnostics
  • Lymphoma
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
View report >

Cancer Statistics in the US

  • April 2008
  • 52 pages

BIOCUREX, INC. ## River Road, Suite ## Richmond, BC, V##X ##X##, Canada Phone: (##) ##-## or (##) ##-## Fax: (##) ##-## www. biocurex. com Novel, Widespread Cancer Marker to Improve Cancer Diagnostics BIOCUREX, INC.

  • Cancer
  • Hospital
  • Lymphoma
  • United States
  • F. Hoffmann-La Roche Ltd.

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on